TSH Biopharm Corporation Limited

TPEX:8432 Rapporto sulle azioni

Cap. di mercato: NT$2.5b

TSH Biopharm Gestione

Gestione criteri di controllo 2/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Sze-Yuan Yang

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO5.8yrs
Proprietà del CEOn/a
Durata media del management4.6yrs
Durata media del Consiglio di amministrazione1.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

Weak Financial Prospects Seem To Be Dragging Down TSH Biopharm Corporation Limited (GTSM:8432) Stock

Feb 18
Weak Financial Prospects Seem To Be Dragging Down TSH Biopharm Corporation Limited (GTSM:8432) Stock

Is TSH Biopharm Corporation Limited (GTSM:8432) An Attractive Dividend Stock?

Jan 21
Is TSH Biopharm Corporation Limited (GTSM:8432) An Attractive Dividend Stock?

TSH Biopharm's (GTSM:8432) Shareholders Are Down 26% On Their Shares

Dec 16
TSH Biopharm's (GTSM:8432) Shareholders Are Down 26% On Their Shares

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Sze-Yuan Yang rispetto agli utili di TSH Biopharm?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

NT$88m

Mar 31 2024n/an/a

NT$92m

Dec 31 2023n/an/a

NT$62m

Sep 30 2023n/an/a

NT$54m

Jun 30 2023n/an/a

NT$55m

Mar 31 2023n/an/a

NT$53m

Dec 31 2022n/an/a

NT$62m

Sep 30 2022n/an/a

NT$68m

Jun 30 2022n/an/a

NT$60m

Mar 31 2022n/an/a

NT$57m

Dec 31 2021NT$6mNT$4m

NT$47m

Sep 30 2021n/an/a

NT$47m

Jun 30 2021n/an/a

NT$53m

Mar 31 2021n/an/a

NT$48m

Dec 31 2020NT$6mNT$5m

NT$62m

Compensazione vs Mercato: Insufficient data to establish whether Sze-Yuan's total compensation is reasonable compared to companies of similar size in the TW market.

Compensazione vs guadagni: Sze-Yuan's compensation has been consistent with company performance over the past year.

AMMINISTRATORE DELEGATO

Sze-Yuan Yang

5.8yrs

Mandato

NT$5,724,000

Compensazione

Ms. Sze-Yuan Yang serves as General Manager at TSH Biopharm Corporation Limited since January 17, 2019. She studied at Institute of Pharmacology, National Yangming University. She has served at TTY Pharmac...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Sze-Yuan Yang
General Manager5.8yrsNT$5.72mNessun dato
Xin-Yang Liu
Vice General Manager of General Administration4.6yrsNT$3.07mNessun dato
Jung-Liang Kao
Chief Financial Officerless than a yearNessun datoNessun dato
Chen-Ju Kan
Senior Manager of the Accounting Departmentno dataNessun datoNessun dato
Jian-Rong Huang
Sales Division Director4.6yrsNessun datoNessun dato
Hsin-Young Liu
Company Secretary4.5yrsNessun datoNessun dato

4.6yrs

Durata media

Gestione esperta: 8432's management team is considered experienced (4.6 years average tenure).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Chuan-Quan Lin
Chairman4.5yrsNessun datoNessun dato
Kang-Chi Chou
Representative Director4.5yrsNessun datoNessun dato
Carl Hsiao
Representative Director4.5yrsNessun dato0.088%
NT$ 2.2m
Rwei-Syun Chen
Independent Directorno dataNessun datoNessun dato
Yaw-Bin Huang
Independent Directorno dataNessun datoNessun dato
Te-Yu Chou
Independent Director1.1yrsNessun datoNessun dato
Yong-Liang Wu
Director1.1yrsNessun datoNessun dato
Yuen-Liang Lai
Independent Directorless than a yearNessun datoNessun dato
Shiow-Ming Wu
Independent Directorless than a yearNessun datoNessun dato

1.1yrs

Durata media

Consiglio di amministrazione esperto: 8432's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.